These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9488718)

  • 1. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl.
    Kragten E; Lalande I; Zimmermann K; Roggo S; Schindler P; Muller D; van Oostrum J; Waldmeier P; Furst P
    J Biol Chem; 1998 Mar; 273(10):5821-8. PubMed ID: 9488718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurorescuing effects of the GAPDH ligand CGP 3466B.
    Waldmeier PC; Boulton AA; Cools AR; Kato AC; Tatton WG
    J Neural Transm Suppl; 2000; (60):197-214. PubMed ID: 11205140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection by pharmacologic blockade of the GAPDH death cascade.
    Hara MR; Thomas B; Cascio MB; Bae BI; Hester LD; Dawson VL; Dawson TM; Sawa A; Snyder SH
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3887-9. PubMed ID: 16505364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms of the neuroprotective effect of (-)-deprenyl].
    Pálfi M; Szökó E; Kálmán M
    Orv Hetil; 2006 Jul; 147(27):1251-7. PubMed ID: 16927880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease.
    Jenner P
    Neurology; 2004 Oct; 63(7 Suppl 2):S13-22. PubMed ID: 15477581
    [No Abstract]   [Full Text] [Related]  

  • 6. Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl.
    Medvedev A; Buneeva O; Gnedenko O; Fedchenko V; Medvedeva M; Ivanov Y; Glover V; Sandler M
    J Neural Transm Suppl; 2006; (71):97-103. PubMed ID: 17447420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B.
    Tatton W; Chalmers-Redman R; Tatton N
    J Neural Transm (Vienna); 2003 May; 110(5):509-15. PubMed ID: 12721812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of tools for target identification of the anti-apoptotic compound CGP 3466; Part I.
    Zimmermann K; Roggo S; Kragten E; Fürst P; Waldmeier P
    Bioorg Med Chem Lett; 1998 May; 8(10):1195-200. PubMed ID: 9871734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer.
    Carlile GW; Chalmers-Redman RM; Tatton NA; Pong A; Borden KE; Tatton WG
    Mol Pharmacol; 2000 Jan; 57(1):2-12. PubMed ID: 10617673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.
    Waldmeier PC; Spooren WP; Hengerer B
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):526-37. PubMed ID: 11138845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage.
    Ou XM; Stockmeier CA; Meltzer HY; Overholser JC; Jurjus GJ; Dieter L; Chen K; Lu D; Johnson C; Youdim MB; Austin MC; Luo J; Sawa A; May W; Shih JC
    Biol Psychiatry; 2010 May; 67(9):855-63. PubMed ID: 20022592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms.
    Naoi M; Maruyama W; Inaba-Hasegawa K
    Expert Rev Neurother; 2013 Jun; 13(6):671-84. PubMed ID: 23739004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide.
    Maruyama W; Takahashi T; Naoi M
    J Neurochem; 1998 Jun; 70(6):2510-5. PubMed ID: 9603216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-apoptotic function of L-(-)deprenyl (Selegiline) and related compounds.
    Naoi M; Maruyama W; Yagi K; Youdim M
    Neurobiology (Bp); 2000; 8(1):69-80. PubMed ID: 11008879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes.
    Maruyama W; Akao Y; Carrillo MC; Kitani K; Youdium MB; Naoi M
    Neurotoxicol Teratol; 2002; 24(5):675-82. PubMed ID: 12200198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain.
    Knoll J
    Pharmacol Toxicol; 1998 Feb; 82(2):57-66. PubMed ID: 9498233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.
    Tatton WG; Wadia JS; Ju WY; Chalmers-Redman RM; Tatton NA
    J Neural Transm Suppl; 1996; 48():45-59. PubMed ID: 8988461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers.
    Naoi M; Maruyama W; Yi H; Akao Y; Yamaoka Y; Shamoto-Nagai M
    J Neural Transm Suppl; 2007; (72):121-31. PubMed ID: 17982885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of R-(-)-deprenyl in adhesion of neuronal and non-neuronal cells].
    Jenei V; Zor K; Magyar K; Jakus J
    Orv Hetil; 2005 Mar; 146(13):601-6. PubMed ID: 15856624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective and neuronal rescue effects of (-)-deprenyl.
    Magyar K; Szende B; Lengyel J; Tarczali J; Szatmáry I
    J Neural Transm Suppl; 1998; 52():109-23. PubMed ID: 9564614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.